New Report Finds 21 Drugs Were Recalled Due to Glass-Related Issues in 2021
April 13, 2022 11:31 ET
|
SiO2 Materials Science
AUBURN, Ala., April 13, 2022 (GLOBE NEWSWIRE) -- SiO2 Materials Science, a privately-owned U.S.-based advanced materials science company, today released the findings from their new report:...
InveniAI to Participate in the Truist Securities Life Sciences AI Symposium – Biotech & Tools
February 24, 2022 12:39 ET
|
InveniAI LLC
GUILFORD, Conn., Feb. 24, 2022 (GLOBE NEWSWIRE) -- InveniAI® LLC, a global leader in applying Artificial Intelligence (AI) and Machine Learning (ML) to transform drug discovery and development,...
InveniAI and Kyowa Kirin Expand AI-Driven Partnership to a Multi-Year Strategic Collaboration for the Discovery of Novel Targets and Treatments Across Therapeutic Areas
December 16, 2021 08:10 ET
|
InveniAI LLC
Collaboration enables Kyowa Kirin's R&D team to access InveniAI's data-driven discovery platform in expanded therapeutic areasInveniAI's AlphaMeld® platform to provide unique Translational Edge...
INCUBATE RAISES CONCERN ABUT PRESIDENT TRUMP'S EXECUTIVE ORDER ON DRUG PRICING
July 31, 2020 17:10 ET
|
Incubate
Washington, DC, July 31, 2020 (GLOBE NEWSWIRE) -- Last week, President Trump signed four Executive Orders (EO) to lower prescription drug costs. One Executive Order was discussed that would import...